Skip to main content

Table 4 Clinical staging and survival analysis

From: Clinical manifestation, staging and prognosis of hepatocellular carcinoma in Gambian patients

Variable

n (%)

Clinical staging

n = 246

Performance status (%): 0/1/2/3/4/5

18 (7.3)/63 (25.2)/69 (28)/54 (22.4)/25 (10.2)/17 (6.9)

n = 203

Barcelona clinic liver cancer staging (%): A/B/C/D

4 (1.9)/8 (3.9) /94 (46.3)/97 (41.8)

n = 209

Child pugh Scoring (%): A/B/C

52 (24.9)/ 97 (46.4) /60 (28.7)

Child Pugh score

8 (5–13)

Survival (Days)

n = 260

Overall median survival

33 (1–510)

  1. Data are median (Range) or n (%)